A recent survey conducted by CVS Health® in collaboration with Morning Consult has revealed a growing concern among adults regarding mental health issues, with rates steadily increasing across the nation. The survey indicates that two-thirds (65%) of adults have expressed…
Substance misuse continues to pose a significant challenge in the United States. Prevention, defined as any action aimed at averting substance misuse and lessening its adverse health and societal impacts, plays a crucial role in promoting mental well-being, preventing substance…
United Health Foundation, the philanthropic arm of UnitedHealth Group , has bestowed a generous three-year, $2.5 million grant upon The Arc of the United States. This grant aims to enhance mental health care for individuals with intellectual and developmental disabilities…
Today, KKR, a prominent global investment firm, revealed the finalization of agreements whereby KKR-managed funds will purchase Healthium Medtech Ltd. (“Healthium”), a top Indian medical devices company, from an affiliate of Funds advised by Apax Partners LLP (“Apax”), a renowned…
MindMed (NASDAQ: MNMD), a clinical-stage biopharmaceutical company focused on developing innovative treatments for brain health disorders, unveiled data from its Phase 2b study of MM120 (lysergide d-tartrate) for treating Generalized Anxiety Disorder (GAD) in adults. The study, known as MMED008,…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech firm focused on pioneering treatments for urothelial and specialty cancers, has unveiled findings from a fresh examination of the ATLAS trial. This analysis employs Kaplan Meier techniques to gauge the likelihood of sustained…
UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company specializing in urothelial and specialty cancer treatments, presents findings from a sub-analysis of JELMYTO (mitomycin) for pyelocalyceal solution at the American Urological Association Meeting 2024. In a cohort of complete responders to…
Smart Meter, a leading provider of Cellular Remote Patient Monitoring (RPM) solutions, has launched the iGlucose Plus, an upgraded version of its popular cellular-connected glucose meter. With its innovative features, the iGlucose Plus aims to revolutionize remote blood glucose monitoring…
Today, GE HealthCare (Nasdaq: GEHC) introduced SIGNA MAGNUS, a head-only magnetic resonance (MR) scanner awaiting FDA 510(k) approval. It’s specifically crafted to propel advancements in neuroscience, addressing limitations of conventional whole-body MR systems. Neuroscience, especially in researching psychiatric conditions and…
Today, Mars, Incorporated revealed it’s in exclusive talks with Cerba HealthCare, aiming to acquire Cerba HealthCare’s ownership stake in Cerba Vet and ANTAGENE Based in Massy, France, Cerba Vet operates six veterinary diagnostics laboratories in France and Switzerland. With about…
Cynergy Wellness to provide clinician oversight of BetterWay™ customer-initiated blood testing orders Babson Diagnostics, a pioneering healthcare technology company with a focus on science, has announced a collaboration with Cynergy Wellness, Inc., a privately-owned provider of nationwide physician services for…
UroGen Pharma Ltd. (Nasdaq: URGN), specializing in innovative treatments for urothelial and specialty cancers, highlights findings from a sub-analysis of real-world patient data on JELMYTO (mitomycin) for pyelocalyceal solution. Presented at the American Urological Association Meeting 2024 in San Antonio,…